SCHEMBL23440327

SCHEMBL23440327

O=C(NCc1ccco1)c1ccccc1NSc1ccc(F)cc1Cl

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 12/20 0.55
▸ SMN1; SMN2 Q16637 5/20 0.55
▸ MAPT P10636 4/20 0.55
▸ POLB P06746 2/20 0.55
▸ ALDH1A1 P00352 5/20 0.52
▸ KDM4E B2RXH2 4/20 0.52
▸ MEN1 O00255 3/20 0.52
▸ KMT2A Q03164 3/20 0.52
▸ TDP1 Q9NUW8 2/20 0.52
▸ NPSR1 Q6W5P4 2/20 0.52
▸ CASP3 P42574 1/20 0.52
▸ SENP7 Q9BQF6 1/20 0.52
▸ SENP6 Q9GZR1 1/20 0.52
▸ L3MBTL1 Q9Y468 1/20 0.52
▸ HTT P42858 5/20 0.49
▸ LMNA P02545 2/20 0.49
▸ TP53 P04637 2/20 0.49
▸ GFER P55789 1/20 0.49
▸ GAA P10253 1/20 0.48
▸ TSHR P16473 3/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23412421 0.80 ALDH1A1 (0.62) HPGDSMN1; SMN2MAPTPOLBALDH1A1
SCHEMBL23440341 0.80 SMN1; SMN2 (0.61) HPGDSMN1; SMN2MAPTPOLBALDH1A1
SCHEMBL23440431 0.79 NPSR1 (0.60) HPGDSMN1; SMN2MAPTPOLBALDH1A1
SCHEMBL23440348 0.77 HPGD (0.60) HPGDSMN1; SMN2MAPTPOLBALDH1A1
SCHEMBL23440433 0.75 TDP1 (0.58) HPGDSMN1; SMN2MAPTPOLBALDH1A1
SCHEMBL23439713 0.75 HPGD (0.60) HPGDSMN1; SMN2MAPTPOLBALDH1A1
SCHEMBL23440346 0.75 HPGD (0.56) HPGDSMN1; SMN2MAPTPOLBALDH1A1
SCHEMBL28908446 0.75 ALDH1A1 (0.67) HPGDSMN1; SMN2MAPTPOLBALDH1A1
SCHEMBL30639190 0.75 HPGD (0.69) HPGDSMN1; SMN2MAPTPOLBALDH1A1
SCHEMBL23440117 0.73 HPGD (0.51) HPGDSMN1; SMN2MAPTPOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021105906-A1 ARYL AND HETEROARYL COMPOUNDS, AND THERAPEUTIC USES THEREOF IN CONDITIONS ASSOCIATED WITH THE ALTERATION OF THE ACTIVITY OF GALACTOCEREBROSIDASE GAIN THERAPEUTICS SA (CH) 2021-06-03 — — WO disclosed
Send feedback